LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 0.35 | |
| Mar2024 | ₹32 Cr | -7.30 | |
| Mar2023 | ₹34 Cr | -20.24 | |
| Mar2022 | ₹43 Cr | 3.93 | |
| Mar2021 | ₹41 Cr | - | |
Compare Contingent Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹210.6 Cr | 16.3% | -10.9% | -45.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 16.3% |
-10.9% |
-45.2% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses